Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/19364933

Download in:

View as

General Info

PMID
19364933